Follow-up Evaluation of Air Force Blood Donors Screening Positive for Chagas Disease

Abstract

Background: Human Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, is endemic to South Texas, and has significant morbidity and mortality related to cardiac toxicity. Consistent with national guidance from the FDA Blood Products Advisory Committee, the Joint Base San Antonio-Lackland blood bank screens all first-time blood donors for T. cruzi infection, currently with a chemiluminescent immunoassay. Although there is a published, standardized approach for diagnosis and evaluation of Chagas disease in the United States, local adherence to this approach has not been studied. Methods: A retrospective chart review was performed on all persons who screened positive for T. cruzion blood donation at Joint Base San Antonio-Lackland from 2014-2016. Charts were reviewed to determine frequency and results of confirmatory testing. Chagas disease was considered confirmed on the basis of positive EIA and TESA testing from the CDC and/or two different positive serologic tests. Among those with diagnosed diseases, charts were further examined to review whether patients underwent the recommended workup of history and physical, EKG, and 30 second rhythm strip; outcomes of these evaluations were ascertained.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 27, 2017
Accession Number
AD1038324

Entities

People

  • Joseph H Marcus

Organizations

  • 59th Medical Wing

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Air Force
  • Biomedical Research
  • Blood Donors
  • Department Of Defense
  • Digital Information
  • Diseases And Disorders
  • Infectious Diseases
  • Institutional Review Board
  • Intellectual Property
  • Law
  • Materials
  • Medical Personnel
  • Military Medicine
  • Technical Information Centers
  • Tissue Donors
  • Trypanosomiasis

Fields of Study

  • Medicine

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Oncology and Biomarker-Based Cancer Detection.
  • Vector-Borne Disease and Entomology